The Information in this section is intended for healthcare professionals only.

Please confirm that you are a healthcare professional.

The Information in this section is intended for healthcare professionals only.

Please confirm that you are a healthcare professional.

Cookies

This site uses cookies for site interaction analysis with a purpose of service quality enhancing and uninterrupted site work. More details in Cookies Policy
Accept
02 September 2021

DARFEN - a complex solution for pain from Darnitsa

02 September 2021

The pharmaceutical company “Darnitsa” has presented a new branded line DARFEN® to fight pain and inflammation in adults and children. The Darfen® brand consists of medicines in the form of gel, pills and suspensions, which contain ibuprofen.

Pain is one of the most common reasons why patients seek primary care. As defined by the International Association study of pain (International Association for the Study of Pain - IASP) it is characterized by unpleasant sensations and emotional distress associated with existing or possible tissue damage.

Without proper treatment, pain can significantly impair the quality of life not only of the patient but also his family, and cause negative consequences for society as a whole. The burden of pain in many cases can be exacerbated by the addition of concomitant conditions such as depression and anxiety. The feeling of pain reduces productivity and can cause social isolation and prolonged disability.

Andrii Obrizan, the General Director of Darnitsa Pharmaceutical Company: “Darfen® is an effective medicine for relieving pain and improving the quality of life of patients. The wide range of products in this brand line and various dosage forms allow you to choose the optimal solution for the treatment of patients of different ages and with different indications. Currently there are four drugs under the Darfen® brand and we plan to expand it further. ”

In pharmacies, Darfen® is represented by the local analgesic Darfen® Gel and oral forms Darfen® Long, Darfen® Kids and Darfen® Kids Forte.

Darfen® Gel is used topically to relieve pain and reduce inflammation in patients suffering from rheumatic, muscle and joint pain, back pain, as well as pain and swelling due to injury, sprains and sports injuries. It is produced in the form of a gel in tubes of 15 g, 50 g and 100 g. It is available without a prescription. Darfen® Gel has a registration certificate №UA / 18641/01/01.

Darfen® Long is a powerful analgesic that provides fast and long-lasting action for up to 9 hours due to the synergy of two analgesic components: ibuprofen and paracetamol. It is recommended for the symptomatic treatment of mild to moderate migraine pain, headaches, back pain, menstrual, dental, rheumatic and muscle pain, pain in mild forms of arthritis, signs of colds and flu, sore throat and fever. It is produced in the form of film-coated tablets of 200 mg/ 500 mg of 10 tablets in a blister. Available without a prescription. Darfen® Long has a registration certificate №UA / 18537/01/01.

The Darfen® kids line helps combat fever and pain with Darfen® Kids and Darfen® Kids Forte for use in children aged 3 and 6 months, respectively. Recommended for the symptomatic treatment of fever and pain of various origins in children, including fever after immunization, acute respiratory viral infections, influenza, teething pain, post-extraction tooth pain, toothache, headache, sore throat, sprain pain and other types of pain, including inflammatory genesis.

Both drugs are available in the form of an oral suspension and are equipped with a convenient syringe-dispenser, which prevents leakage of the drug. Darfen® Kids and Darfen® Kids Forte do not contain sugar and coloring, and have a pleasant strawberry taste. The effect of Darfen® Kids Forte starts 15 minutes after application. The duration of action of Darfen® Kids Forte lasts up to 8 hours.

Darfen® Kids has a registration Certificate №UA / 18549/01/01. Registration certificate of Darfen® Kids Forte is №UA / 18550/01/01.

Consult a doctor before using the medication.

Share:
Specialized edition for medical institutions and doctors.